Table 4.
Susceptibility profiles of bacterial isolates
| Isolate | Antibacterial agent | |||||||
|---|---|---|---|---|---|---|---|---|
| CIP | CN | C | CXM | AMX | AUG | CAZ | CRO | |
| Staphylococcus aureus (n=139) | 37 (26.6) | 75 (54.0) | 8 (5.8) | 99 (71.2) | 38 (27.3) | 67 (96.2) | 62 (44.6) | 2 (1.4) |
| Escherichia coli (n=10) | 1 (10.0) | 6 (60.0) | 0 (0.0) | 6(60.0) | 0 (00.0) | 2(20.0) | 1 (10.0) | 0 (0.0) |
| Klebsiella species (n=79) | 23(29.1) | 27 (34.2) | 9 (11.4) | 29 (36.7) | 0 (0.0) | 39 (49.4) | 21 (26.6) | 0 (0.0) |
| Citrobacter freundii (n=1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Enterobacter species (n=5) | 0 (0.0) | 3 (60.0) | 0 (0.0) | 3 (60.0) | 1 (20.0) | 0 (0.0) | 2(40.0) | 0 (0.0) |
| Proteus species (n=47) | 22 (46.8) | 28 (59.6) | 5 (10.6) | 25 (53.2) | 0 (0.0) | 23 (48.9) | 20 (42.6) | 0 (0.0) |
| Previdencia species (n=7) | 3 (42.9) | 3 (42.9) | 0 (0.0) | 6 (85.7) | 0 (0.0) | 1(14.3) | 3 (42.9) | 0 (0.0) |
| Pseudomonas aeruginosa(n=10) | 1 (10.0) | 7 (70.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 7 (70.0) | 0 (0.0) |
| Alkaligenes species(n=70) | 15 (21.4) | 50 (71.4) | 22 (31.4) | 39 (55.7) | 18 (25.7) | 30(42.6) | 24 (34.2) | 0 (0.0) |
| Acinetobacter species (n=13) | 1 (7.7) | 5 (38.5) | 1 (7.7) | 9 (69.2) | 0 (0.0) | 7 (53.9) | 5 (38.5) | 0 (0.0) |
CIP=ciprofloxacin, CN=Gentamicin, C=Chloramphenicol, CXM=Cefuroxime, AMX=Amoxicillin, AUG=Amoxicillin – clavunate
CAZ=Ceftazidime, CRO=Ceftriaxone, n=number tested, figures in parenthesis are percentages.